Mutual Fund Ownership
Ownership as on: Wed, 17 Apr, 2024

UTI Healthcare Fund Regular Plan Growth

NA
Equity
Amount Invested (Cr.)56.00
% of AUM5.91%

HDFC Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)41.55
% of AUM5.19%

WhiteOak Capital Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)4.79
% of AUM4.41%

Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)29.10
% of AUM4.16%

Kotak Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)8.86
% of AUM3.12%

FAQs about Ajanta Pharmaceuticals share price

Ajanta Pharmaceuticals is trading at 2060.75 as on Tue Apr 16 2024 09:57:19. This is -2.13% lower as compared to its previous closing price of 2105.50.

The market capitalization of Ajanta Pharmaceuticals is 25948.07 Cr as on Tue Apr 16 2024 09:57:19.

The average broker rating on Ajanta Pharmaceuticals is Buy. The breakup of analyst rating is given below -

  • 5 analysts have given a strong buy rating
  • 2 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 1 analysts have given a sell rating
  • 1 analysts have given a strong sell rating

The 52 wk high for Ajanta Pharmaceuticals is 2355.05 whereas the 52 wk low is 1221.24

Ajanta Pharmaceuticals can be analyzed on the following key metrics -

  • TTM P/E: 35.76
  • Sector P/E: 30.17
  • Dividend Yield: 0.82%
  • D/E ratio: -

Ajanta Pharmaceuticals reported a net profit of 587.98 Cr in 2023.

Recommended For You
Trending Stocks
3,647.05+45.50(1.26%)
2,220.90+26.30(1.20%)
1,509.40+14.45(0.97%)
1,414.75-53.55 (-3.65%)
1,490.75-48.05 (-3.12%)